Current Radiotherapy Considerations for Nasopharyngeal Carcinoma

被引:26
|
作者
Ng, Wai Tong [1 ,2 ,3 ]
Chow, James C. H. [4 ]
Beitler, Jonathan J. [5 ]
Corry, June [6 ]
Mendenhall, William [7 ]
Lee, Anne W. M. [1 ,2 ]
Robbins, K. Thomas [8 ]
Nuyts, Sandra [9 ]
Saba, Nabil F. [10 ]
Smee, Robert [11 ]
Stokes, William A. [12 ]
Strojan, Primoz [13 ]
Ferlito, Alfio
机构
[1] Univ Hong Kong, Shenzhen Hosp, Clin Oncol Ctr, Shenzhen 518009, Peoples R China
[2] Univ Hong Kong, Shenzhen Hosp, Shenzhen Key Lab Canc Metastasis & Personalized Th, Shenzhen 518009, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China
[4] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China
[5] Knox Cty Hlth Clin, Rockland, ME 04841 USA
[6] St Vincents Hosp, Div Radiat Oncol, GenesisCare Radiat Oncol, Melbourne, Vic 3065, Australia
[7] Univ Florida, Dept Radiat Oncol, Coll Med, Gainesville, FL 32610 USA
[8] Southern Illinois Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Springfield, IL 62794 USA
[9] Univ Leuven, KU Leuven, Univ Hosp Leuven, Dept Radiat Oncol, B-3000 Leuven, Belgium
[10] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA
[11] Prince Wales Canc Ctr, Dept Radiat Oncol, Sydney, NSW 2031, Australia
[12] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA
[13] Inst Oncol, Dept Radiat Oncol, Ljubljana 1000, Slovenia
关键词
nasopharyngeal cancer; radiotherapy; target delineation; adaptive planning; artificial intelligence; particle therapy; INTENSITY-MODULATED RADIOTHERAPY; CLINICAL TARGET VOLUME; LYMPH-NODE DISTRIBUTION; QUALITY-OF-LIFE; RADIATION-THERAPY; ARTIFICIAL-INTELLIGENCE; INDUCTION CHEMOTHERAPY; TREATMENT OUTCOMES; PROTON THERAPY; NCIC CTG;
D O I
10.3390/cancers14235773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Nasopharyngeal carcinoma (NPC) is commonly treated using high-dose radiotherapy. Careful radiotherapy planning is crucial for the eradication of cancer cells while avoiding injuries to normal structures. This balance is often delicate given the complex anatomic location in which NPC is situated. This article highlights the considerations, practical pearls, and recent advances in the precise delivery of radiotherapy in NPC patients. Radiotherapy is the primary treatment modality for nasopharyngeal carcinoma (NPC). Successful curative treatment requires optimal radiotherapy planning and precise beam delivery that maximizes locoregional control while minimizing treatment-related side effects. In this article, we highlight considerations in target delineation, radiation dose, and the adoption of technological advances with the aim of optimizing the benefits of radiotherapy in NPC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Causes of interruption of radiotherapy in nasopharyngeal carcinoma patients
    Chen, YP
    Tsang, NM
    Tseng, TK
    Hung, JH
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S166 - S166
  • [42] Epilepsy related to radiotherapy in patients with nasopharyngeal carcinoma
    Tang, Yamei
    Li, Yi
    Luo, Donghua
    Rong, Xiaoming
    Ye, Jianhong
    Peng, Ying
    EPILEPSY RESEARCH, 2011, 96 (1-2) : 24 - 28
  • [43] Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma
    Ulger, Sukran
    Ulger, Zerkeriya
    Yildiz, Ferah
    Ozyar, Enis
    MEDICAL ONCOLOGY, 2007, 24 (01) : 91 - 94
  • [44] Impact of the radiotherapy rhythm on prognosis in nasopharyngeal carcinoma
    Li, Ying
    Chen, Xiaochuan
    Wu, Lishui
    Huang, Zongwei
    Xu, Siqi
    Hong, Xinyi
    Lai, Jinghua
    Qiu, Sufang
    Zheng, Xiong
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [45] STEREOTACTIC RADIOTHERAPY FOR LOCALLY RECURRENT NASOPHARYNGEAL CARCINOMA
    Leung, To-Wai
    Wong, Victy Y. W.
    Tung, Stewart Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : 734 - 741
  • [46] Carotid stenosis after radiotherapy for nasopharyngeal carcinoma
    Cheng, SWK
    Ting, ACW
    Lam, LK
    Wei, WI
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2000, 126 (04) : 517 - 521
  • [47] Stereotactic radiotherapy in nasopharyngeal carcinoma - Preliminary results
    Dhanachai, M
    Kraiphibul, P
    Pochanugool, L
    Dangprasert, S
    Sitathanee, C
    Laothamatas, J
    Kulapraditharom, B
    Theerapancharoen, V
    Sirisinha, T
    Yongvithisatid, P
    Assavaprathuangkul, P
    Boonpitak, K
    RADIOSURGERY, VOL 4, 2002, 4 : 162 - 166
  • [48] Combinatorial strategies of radiotherapy and immunotherapy in nasopharyngeal carcinoma
    Yeo, Eugenia L. L.
    Li, You Quan
    Soo, Khee-Chee
    Wee, Joseph T. S.
    Chua, Melvin L. K.
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (02)
  • [49] The role of PET/CT in radiotherapy for nasopharyngeal carcinoma
    Li, Hongjia
    Kong, Ziren
    Xiang, Yongbo
    Zheng, Rong
    Liu, Shaoyan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [50] Nasopharyngeal carcinoma:: Radiotherapy alone or in combination with chemotherapy?
    Grüner, A
    Grabenbauer, GG
    Rödel, C
    Weidenbecher, M
    Martus, P
    Iro, H
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (12) : 591 - 596